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Abstract
The Mycobacterium tuberculosis complex is associated with a remarkably low level of
structural gene polymorphism. As part of a search for alternative forms of genetic
variation that may act as a source of biological diversity in M. tuberculosis, we have
identi®ed a region of the genome that is highly variable amongst a panel of unrelated
clinical isolates. Fifteen of 24 isolates examined contained one or more copies of the M.
tuberculosis-speci®c IS6110 insertion element within this 20 kb variable region. In nine of
the isolates, including the laboratory-passaged strain H37Rv, genomic deletions were
identi®ed, resulting in loss of between two and 13 genes. In each case, deletions were
associated with the presence of a copy of the IS6110 element. Absence of ¯anking tri- or
tetra-nucleotide repeats identi®ed homologous recombination between adjacent IS6110
elements as the most likely mechanism of the deletion events. IS6110 insertion into hot-
spots within the genome of M. tuberculosis provides a mechanism for generation of genetic
diversity involving a high frequency of insertions and deletions. Copyright # 2000 John
Wiley & Sons, Ltd.
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Introduction
Mycobacterium tuberculosis is a highly successful
human pathogen, infecting up to one-third of the
global population and causing around two million
deaths annually (Dye et al., 1999). Successful
pathogenesis is dependent on a combination of
attributes, including the ability to resist killing by
phagocytes, to establish a prolonged latent infection
in healthy individuals and to exploit opportunities
for active growth and aerosol transmission. De®ni-
tion of the cellular and molecular mechanisms
underlying these different stages of infection pre-
sents an important challenge in tuberculosis
research. It has long been recognized that isolates
of M. tuberculosis cultured from individual patients
vary in their ability to survive under different
conditions in the laboratory and to cause progres-
sive infection in animals (Mitchison et al., 1963;
Ordway et al., 1995). Similarly, epidemiological
studies demonstrate heterogeneity in transmissibil-
ity and virulence amongst different isolates, as
judged by rates of skin test conversion and onset
of clinical disease amongst exposed contacts
(Valway et al., 1998; Rhee et al., 1999). Investiga-
tion of genetic variation amongst M. tuberculosis
isolates may provide insights into mycobacterial
pathogenesis. By matching genetic differences
between isolates with particular clinical or epide-
miological patterns, it may be possible to identify
genes that in¯uence the biology of tuberculosis
infection, and to understand the forces of microbial
evolution that contribute to the success of this
pathogen in a wide range of historical and
geographical settings.
Comparative analysis of nucleotide sequences of
a panel of structural genes has been used as an
approach to investigate the extent of strain diversity
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(which includes the predominant veterinary
pathogens M. bovis and M. microti as well as the
major human pathogens M. tuberculosis and M.
africanum) (Sreevatsan et al., 1997). This approach
uncovered a striking absence of allelic variation,
generating ®ndings consistent with a model in
which M. tuberculosis evolved to its present form
as a result of an evolutionary `bottleneck' around
15 000±20 000 years ago. In contrast, a more
extensive diversity has been revealed by whole
genome comparisons within the M. tuberculosis
complex (Behr et al., 1999; Gordon et al., 1999). A
series of chromosomal deletions were identi®ed,
with around 100 of the 4000 genes present in M.
tuberculosis being absent from the genome of M.
bovis isolates. A further 30 genes were found to
have been selectively lost during the years of in vitro
culture of M. bovis that led to generation of the
current set of attenuated isolates used for prepara-
tion of the BCG (bacille Calmette Gue Ârin) vaccine.
These genetic differences may underlie variations in
host speci®city of the pathogenic isolates, and are
most probably responsible for attenuation of the
vaccine strains (Behr et al., 1999).
Amongst isolates of M. tuberculosis itself,
genome variation is evident from patterns revealed
by pulsed-®eld gel electrophoresis (Zhang et al.,
1992). Factors that contribute to this genetic
heterogeneity are known to include differences in
the copy number and location of an M. tubercu-
losis-speci®c insertion sequence (IS6110), variations
amongst a set a polymorphic GC-rich sequences
(PGRS) present in genes encoding a family of
proteins with unknown function, and short variable
sequences interspersed within an apparently non-
coding region of the genome characterized by the
presence of a series of direct repeat elements (the
`DR region') (van Embden et al., 1993; Chaves
et al., 1996; Kamerbeek et al., 1997). These markers
have been extensively employed for strain-typing ±
proving particularly useful in identi®cation of
clusters associated with transmission chains (Small
et al., 1994) ± but their potential contribution to
variation in phenotypic properties of the different
isolates has received less attention.
The present study was initiated with the aim of
identifying sites of genetic variation amongst M.
tuberculosis isolates that may contribute to differ-
ences in the biological properties of the organisms.
To identify candidate loci, the genome of M.
tuberculosis H37Rv ± a well-characterized isolate
for which the complete sequence has been deter-
mined (Cole et al., 1998) ± was analysed for
evidence of IS6110-mediated gene disruption.
There are 16 copies of the IS6110 insertion element
in the H37Rv; ®ve of these are inserted within
predicted open reading frames (ORFs) (Sampson
et al., 1999). One of the IS6110 insertions, encoded
by Rv1756c and Rv1757c, is associated with
truncation of the N-terminal region of two ORFs
arranged in opposite orientations and predicted to
encode phospholipase C (plcD) and cutinase
enzymes (Rv1755c and Rv1758, respectively). The
N-terminal portions that are missing from the two
H37Rv ORFs are present in the genome of a second
well-characterized clinical isolate, CDC1551
(Valway et al., 1998), together with three additional
intervening ORFs which are not found in H37Rv
(Figure 1). The missing genes are also present in the
laboratory-attenuated strain H37Ra (Brosch et al.,
1999) and correspond to the RvD2 deletion initially
described as being present in M. bovis but absent
from H37Rv (Gordon et al., 1999). In the present
study, we have analysed this region in a panel of
clinical isolates of M. tuberculosis, and have
identi®ed it as an area of extensive genetic diversity




The nucleotide sequence of M. tuberculosis H37Rv
from the Sanger Centre (http://www.sanger.ac.uk/
Projects/M_tuberculosis/) was compared to the
sequence of cosmid Y28 (Accession No. Z95890)
and the incomplete and unannotated nucleotide
sequence of M. tuberculosis CDC1551 (The Institute
for Genome Research, http://www.tigr.org, October
1998 version) using the BLAST 2.0 programme at
the National Center for Biotechnology Information
(NCBI, http://www4.ncbi.nlm.nih.gov/BLAST). The
Genemark programme (European Bioinformatics
Institute, http://www2.ebi.ac.uk/genemark) was then
used to predict open reading frames (ORFs) of
sequences present in the CDC1551 strain. These
ORFs were compared against the EMBL databases,
using BLAST to look for similar sequences. Sub-
sequently, partial annotations for ORFs of the
CDC1551 strain became available (http://www.
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1999 version). These are pre®xed in the text with
`MT' followed by the ORF number. In contrast,
ORFs referring to the H37Rv strain are pre®xed
with `Rv'.
Clinical isolates and DNA extraction
Clinical isolates of M. tuberculosis were taken from
cultures derived from clinical specimens isolated in
the Mycobacteria Laboratory at St Mary's Hospi-
tal, Paddington, London, UK. All of the patients
were infected with drug-sensitive strains, and
responded to conventional therapy. A culture of
the clinical isolate CDC1551 was kindly provided
by Dr Jack Crawford at the Centers for Disease
Control and Prevention, Atlanta, GA, USA. Cul-
tures were grown in Middlebrook 7H9 medium,
supplemented with albumin, dextrose and catalase
(Difco). Genomic DNA was extracted from cultures
in the exponential phase of growth by standard
phenol±chloroform extraction, as described pre-
viously (Goyal et al., 1997), and made up in
HPLC grade water at a concentration of approxi-
mately 50 mg/ml.
Ampli®cation by polymerase chain reaction
(PCR)
All reactions were carried out using a 48-well
Hybaid Touchdown PCR thermocycler (Hybaid).
A standard 25 ml reaction mixture was used con-
taining 25 pmol of each primer in 1 ml, 2.5 mlo fa
2m M deoxyribonucleotide mix, 2.5 ml1 0 r reaction
buffer (Promega), 2 ml5 m M MgCl2 and 1.5 units
Taq polymerase (Promega). To this was added 3 ml
Table 1. PCR primers and conditions








Standard ampli®cations (Taq polymerase)
Probe for IS6110 INS1 CGT GAG GGC ATC GAG GTG GC 66 40 s 226
INS2 GCG TAG GCG TCG GTG ACA AA
Rv1754c fragment PR1 TTC ATA CCG TTG GTG TAG AGC 59 15 s 224
PR2 GGA CTC ATG GTT CCA ATA GG
plcD fragment P1 CAG CGA AGT TGA ACG TTG AC 65 2 min 10 s 592
P2 CTT ACT TAC GGC TCG CTT GT
Cutinase fragment C1 ACC ACG GAT TTC CCG ACA GC 67 30 s 411
C2 AAA CAC TGC GGC CTG CTC G
plcD to cutinase P2 CTT ACT TAC GGC TCG CTT GT 57 2 min 1556
C3 GAT GGC CGG TAT TTA CGA C
Rv1766-1767 fragment R1 GTT GAA GGA ATG CGT GTC C 59 16 s 237
R2 GGG AAT CTG GTG ACG TAG A
MT1801 fragment M3 AGA ATT ACT TTC AGG CTC TGG A 58 15 s 178
M4 CCA TCC CAT AGC CAC GAA T
Rv1760 fragment V1 ATG GAG CGA CTA AGC GGA CT 64 15 s 186
V2 GCG AGC TTC ATC CGA AAT T
Extended ampli®cations (eLONGase mix)
plcD to mmpl4 NP2 ACA AGC GAG CCG TAA GTA AG 60 6 min 5690
M2 TTT GGT GAG ACA AAA TAG TCC A
mmpl4 to Rv1758 (cutinase) M1 GAC TAT TTA CGC GAA CTT GCC 64 3 min 2797
C3 GAT GGC CGG TAT TTA CGA C
Rv1754c to Rv1758 PR3 AAT GCG GAT ATC AGT GGA C 64 4 min 30 s
1 2961
C3 GAT GGC CGG TAT TTA CGA C
Rv1754c to Rv1767 PR3 AAT GCG GAT ATC AGT GGA C 59 6 min 40 s
2 13939
R2 GGG AAT CTG GTG ACG TAG A
Rv3324c to Rv3328c MolyF TTC ATC AAG GTG GGT AAG C 58 6 min 11 s 3464 (Rv)
MolyR AGG TGG TCC GGT TCA TAC T 6170 (CDC)
17 ml eLONGase buffer A, 3 ml eLONGase buffer B, 2.5 ml dimethyl sulphoxide.
22.5 ml Dimethyl sulphoxide.
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with HPLC grade water (Sigma-Aldrich). Thermo-
cycling parameters were as follows: 1 cycle at 94uC
for 30 s, held at 85uC while the Taq enzyme was
added, followed by 35 cycles of 94uC for 30 s, 30 s
at the speci®ed annealing temperature, 72uC for the
speci®c extension time required, followed by a ®nal
cycle at 72uC for 3 min.
For predicted products greater than 2 kb, PCR
was performed using the eLONGase enzyme mix
(Gibco/BRL). Each 50 ml PCR reaction mixture
contained 25 pmol of each primer, 5 ml2m M deoxy-
ribonucleotide mix, 5 ml5 r eLONGase Buffer A,
5 ml5 r eLONGase Buffer B (unless otherwise
stated) and 2 ml eLONGase enzyme mix. To this
was added 3 ml DNA solution and the volume made
up to 50 ml with HPLC grade water (Sigma-
Aldrich). Thermocycling parameters were as fol-
lows: 1 cycle at 94uC for 30 s, held at 85uC while the
enzyme mix was added, followed by 35 cycles of
94uC for 30 s, 30 s at the speci®ed annealing
temperature, 68uC for the speci®c extension time
required, followed by a ®nal cycle at 68uC for
10 min. Details of primer pairs, speci®c annealing
temperatures and extension times are listed in
Table 1.
PCR products were examined by routine gel
electrophoresis performed on 1% (w/v) agarose
gels in TAE buffer. Products for sequencing were
excised using a sterile scalpel blade and puri®ed
using the GENECLEAN II kit (Bio 101), according
to the manufacturer's instructions.
Dot-blot hybridization
A2ml sample of PCR product ampli®ed using the
M1/C3 primer pair was denatured by heating at
94uC for 2 min, snap-cooled on ice, and applied to a
Hybond N
+ membrane (Amersham) and air-dried.
The DNA was cross-linked to the membrane using
a UV cross-linker (Stratagene). As a probe, 1 mg
INS1/INS2 amplicon from IS6110 was labelled for
16 h using the DIG High Prime DNA labelling kit
(Boehringer-Mannheim), in accordance with the
manufacturer's instructions. The membrane was
prehybridized using DIG Easy Hyb (Boehringer-
Mannheim) for 1 h at 37uC. The probe was
denatured by boiling for 5 min and snap-cooled in
ice-water. The probe was then added to the
hybridization bottle and incubated overnight at
37uC. Post-hybridization washes and chemilumines-
cence detection steps were carried out according to
the manufacturer's protocol, using the Boehringer-
Mannheim Detection kit.
Figure 1. Organization of the plcD-cutinase region in M. tuberculosis isolates H37Rv and CDC1551
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Cycle sequencing of PCR products was performed
using a Hybaid Touchdown PCR machine and
dichlororhodamine dye terminator ready reaction
mixture (PE Biosystems) in accordance with the
manufacturer's protocol. Subsequent analysis was
performed on an ABI 310 Genetic analyser (PE
Biosystems). The primers used for sequencing were:
PLC2, 5k CAC TAG CCG AGA CGA TCA AC 3k;
and PLC3, 5k CGC CTG GCG CAC CCA CTT AC
3k.
Results
Analysis of plcD-cutinase region
To assess the frequency of diversity in the plcD-
cutinase region (Figure 1), a panel of 22 unrelated
clinical isolates of M. tuberculosis was collected
from patients attending the tuberculosis clinic at St.
Mary's Hospital. The isolates were selected to
represent a range of disease presentations, including
involvement of pulmonary and extrapulmonary
sites, and smear-positive and smear-negative speci-
mens at the time of diagnosis (Table 2). Together
with the well-characterized H37Rv and CDC1551
isolates, this panel was screened using a series of
PCR assays to characterize the plcD gene, the
cutinase gene and the intervening region.
Phospholipase C
A PCR assay was set up using primers P1 and P2 to
amplify a 0.6 kb fragment from the plcD gene
described in the M. tuberculosis H37Rv genome
sequence (Cole et al., 1998). Initial standardization
of this assay, using H37Rv cultures from our
laboratory stock, generated a larger than expected
product of approximately 2 kb. Analysis of this
fragment demonstrated the presence of an addi-
tional copy of the IS6110 insertion element inter-
rupting the C-terminal portion of the protein. A
similar insertion was previously reported during
analysis of cosmid clone Y28 at an intermediate
stage of the H37Rv sequencing project (Z95890,
EMBL release 52, May 1997), but was not found in
the BAC library used to complete the de®nitive
H37Rv genome sequence (Cole et al., 1998).
Analysis of the nucleotide sequence in our local
H37Rv isolate identi®ed the point of insertion at
Table 2. Clinical isolates of Mycobacterium tuberculosis
Patient Disease site Sex Smear status Racial origin Genotype*
TH1 Lymph node Male Negative Sudanese D
TH2 Lymph node Female Negative Philippino U
TH3 Lymph node Male Negative Somalian U
TH4 Lymph node Female Negative Somalian D
TH5 Lymph node Male Negative Somalian U
TH6 Lymph node Male Negative Chinese U
TH7 Lymph node Female Negative Saudi Arabian D
TH8 Chest wall Male Negative Somalian I
TH9 Spine Female Positive Caucasian (Albanian) D
TH10 Sputum Male Positive Moroccan I
TH11 Sputum Male Positive Afro-Caribbean I
TH12 Sputum Male Negative Somalian D
TH13 Sputum Female Negative Indian D
TH14 Sputum Male Negative Indian U
TH15 Sputum Male Positive Algerian D
TH16 Sputum Female Positive Eritrean U
TH17 Sputum Female Positive Somalian U
TH18 Sputum Female Positive Indian I
TH19 Sputum Male Negative Indian U
TH20 Sputum Male Positive Bangladeshi U
TH21 Sputum Male Positive Caucasian (Ukrainian) D
TH22 Sputum Male Negative Caucasian (British) I
*Genotype within 20 kb hypervariable island. U=unmodi®ed; I=insertional inactivation; D=gene deletion.
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described in the Y28 sequence. This ®nding demon-
strates a degree of heterogeneity in the pattern of
IS6110 insertions in the plcD-cutinase region
amongst H37Rv cultures derived from a single
initial source. Application of the PCR assay to the
panel of clinical isolates identi®ed one further
sample (TH11) with an IS6110 insertion affecting
the C-terminal region of phospholipase C. The
point of insertion in this case was at a position
371 bp downstream from the H37Rv insertion.
Amongst the other isolates, 15 generated the
expected 0.6 kb fragment (TH2, 3, 5, 6, 8, 9, 10,
14, 16, 17, 18, 19, 20, 22 and CDC1551), while the
remaining seven isolates produced no detectable
PCR product (TH1, 4, 7, 12, 13, 15, 21) (Table 3).
Cutinase
A second PCR assay was established using primers
C1 and C2 to amplify a 0.4 kb fragment identi®ed
in the H37Rv cutinase sequence. In this case, the
expected product was obtained from 16 of the
isolates. Of the remaining six isolates that did not
amplify (TH1, 7, 9, 12, 13, 21), all but one (TH9)
had also failed to produce a result with the plcD
assay.
Three PCR assays were then used to characterize
the regions encoding the N-terminal portions of the
phospholipase and cutinase enzymes, together with
the region linking the two genes. Primers spanning
from the plcD to the cutinase genes (NP2/C3)
ampli®ed a 1.5 kb fragment from H37Rv (corre-
sponding to the IS6110 insertion element recorded
in the genome sequence), but failed to generate a
product with CDC1551 or with any of the clinical
isolates. Products were obtained, however, when the
reaction was redesigned to amplify two shorter
products, using primers based on the sequence of
MT1802, an ORF absent from H37Rv but lying
between plcD and the cutinase gene in CDC1551
(Figure 1). The isolates could be divided into three
groups on the basis of results with primers M1 and
C3, amplifying the region from MT1802 to the
cutinase (Figure 2). Four isolates, TH8, 10, 18 and
22, generated a 3 kb product (identical to that
predicted from the CDC1551 sequence). A 1.5 kb
product was obtained from a further 10 isolates
(TH2, 3, 5, 6, 11, 14, 16, 17, 19, 20), while the
remaining eight isolates (TH1, 4, 7, 9, 12, 13, 15, 21)
resembled H37Rv in generating no product. Hybri-
dization experiments identi®ed the presence of the
IS6110 insertion element in each of the 3 kb
products. The point of insertion was determined
by sequencing the ¯anking regions at both ends of
the IS6110 element. In two of the isolates, TH8 and
TH22, the insertion was located within the cutinase
gene at a location identical to that observed in the
H37Rv and CDC1551 sequences (position
1 989 056), although in TH22 the orientation of
IS6110 was opposite to that seen in the character-
ized strains. In the two other isolates (TH10 and
18), the insertion occurred at a point 22 bp further
downstream. Primers NP2 and M2 ± designed to
amplify the region from plcD to MT1802 ±
Figure 2. Gel electrophoresis of PCR products generated with M1/C3 primers.Three different patterns were found
following PCR ampli®cation of a region spanning genes encoding membrane protein MT1801 and cutinase, characterized by
the presence of a 3.0 kb fragment, a 1.5 kb fragment, or the absence of any detectable product. Lane 1, negative control; 2,
CDC1551; 3, TH6; 4, TH16; 5, TH20; 6, TH14; 7, TH22; 8, TH8; 9, TH10; 10, TH19; 11, TH3; 12, 1 kb ladder
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from the 14 clinical isolates positive in the plcD
PCR assay.
The results of the above analyses (summarized in
Table 3) demonstrated that in nine of the isolates
(TH2, 3, 5, 6, 14, 16, 17, 19, 20) the intact plcD and
cutinase genes were present together with the three
intervening genes in the absence of any IS6110
insertion. In a further four isolates (TH8, 10, 18, 22)
and CDC1551, all of the genes were present, but in
each case the cutinase gene was interrupted by
IS6110 inserted in either orientation at one of two
sites. In one isolate (TH11), the genes were intact
with the exception of an insertion in plcD. Char-
acterization of the plcD-cutinase region in the
remaining eight isolates (TH1, 4, 7, 9, 12, 13, 15,
21) was frustrated by the absence of either or both
of the plcD and cutinase genes.
Table 3. Genetic diversity within the variable island
Isolate number











TH2 0.6 0.4 1.5 None
TH3 0.6 0.4 1.5 None
TH5 0.6 0.4 1.5 None
TH6 0.6 0.4 1.5 None
TH14 0.6 0.4 1.5 None
TH16 0.6 0.4 1.5 None
TH17 0.6 0.4 1.5 None
TH19 0.6 0.4 1.5 None
TH20 0.6 0.4 1.5 None
Insertion isolates
TH8 0.6 0.4 3.0 Cutinase 1 989 056
TH10 0.6 0.4 3.0 Cutinase 1 989 078
TH11 2.0 0.4 1.5 plcD 1 987 457
TH18 0.6 0.4 3.0 Cutinase 1 989 078
TH22 0.6 0.4 3.0 Cutinase 1 989 056
CDC1551 0.6 0.4 3.0 Cutinase 1 989 056
Deletion isolates
TH1 ND ND ND plcD 1 987 086 19.2
ISB9 1 998 791
TH4 ND 0.4 ND Rv1754c 1 986 620 9.3
Cutinase 1 989 079
TH7 ND ND ND plcD 1 987 086 19.2
ISB9 1 998 791
TH9 0.6 ND ND Cutinase* 1 975 232 8.6
MT1812* 1 983 811
TH12 ND ND ND plcD 1 987 455 18.9
ISB9 1 998 847
TH13 ND ND ND plcD 1 987 455 18.8
ISB9 1 998 748
TH15 ND 0.4 ND Rv1754c 1 986 616 9.3
Cutinase 1 989 081
TH21 ND ND ND Rv1754c 1 986 639 19.5
ISB9 1 998 621
H37Rv 0.6 0.4 ND plcD 1 987 746 6.8
Cutinase 1 989 056
Rv1763 1 996 150 0.7
Rv1764 1 997 411
H37Rv (St Mary's) 2.0 0.4 ND plcD insertion 1 987 086
*Refers to CDC1551 gene positions. All other positions are relative to H37Rv. ND: No detectable product.
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Upstream genes
To characterize the remaining eight clinical isolates,
a series of PCR primers were designed to test for
the presence of genes lying outside the plcD-
cutinase region (Figure 3). All eight isolates gener-
ated positive results using a PCR assay (primers
PR1/PR2) designed to amplify a 0.2 kb fragment
from the ORF directly upstream of plcD (Rv1754c,
encoding a proline-rich protein). In the case of the
two isolates which were positive for the cutinase
gene (TH4, 15), primers based on cutinase and
Rv1754c ampli®ed 1.8 kb fragments, each contain-
ing a copy of the IS6110 insertion element.
Sequence analysis identi®ed adjacent, but distinct,
insertion points in the two isolates (Table 3). In
each case the IS6110 element joined Rv1754c
directly to the cutinase, and was associated with
loss of the intervening genes.
Downstream genes
Positive results were generated from the remaining
six cutinase-negative isolates (TH1, 7, 9, 12, 13, 21)
using PCR primers R1 and R2 directed towards a
0.2 kb fragment overlapping downstream ORFs
Rv1766 and Rv1767 (Figure 3). Further ampli®ca-
tion reactions using R2 in combination with
primers from Rv1754c (PR3) and MT1802 (M1)
generated products from each of the isolates. Each
of the products contained a copy of the IS6110
insertion sequence, and in each case the insertion
was associated with loss of intervening genes. In
four of the isolates (TH1, 7, 12, 13), IS6110 linked a
portion of the plcD gene to an intergenic region
annotated as having homology to a possible
insertion element (ISB9). In two of these isolates
(TH1, 7) the plcD insertion was at the same point as
the additional C-terminal insertion identi®ed in
cosmid Y28 and in our local H37Rv culture; in the
other two isolates (TH12, 13) the insertion point
was 369 bp closer to the 5k end of the gene. In a ®fth
isolate, TH21, the IS6110 insertion element linked
Rv1754c directly to the ISB9 region, with the loss of
all of the intervening ORFs, while the ®nal isolate
(TH9) had an insertion joining the cutinase gene to
MT1812, an ORF present in CDC1551 but absent
from H37Rv (Figure 3).
Figure 3. Mapping of insertions and deletions within the 20 kb variable island
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A potential mechanism to account for the presence
of IS6110 elements in association with gene deletion
has been proposed by Fang et al. (1999). This
involves a homologous recombination event
between adjacent copies of IS6110, and is accom-
panied by loss of the characteristic three or four
nucleotide direct repeat ¯anking IS6110 elements
involved in the normal insertion process. To
evaluate the possible contribution of this mechan-
ism to the results described above, sequences
¯anking each side of the IS6110 insertions were
determined. In each case, when IS6110 was linked
to the loss of genes, the ¯anking direct repeat was
absent, consistent with the recombination-mediated
deletion mechanism.
Screening of sequences ¯anking IS6110 insertion
elements in the H37Rv genome (Cole et al., 1998)
identi®es four copies lacking the trinucleotide
repeat. The un¯anked copies have each been
shown to be associated with deletions from H37Rv
when compared to other M. tuberculosis and M.
bovis isolates and have been annotated as RvD2 to
RvD5, respectively (Brosch et al., 2000). One is
involved in the plcD-cutinase deletion (RvD2), and
a second is associated with the deletion of MT1812
and MT1813 (RvD3), illustrated in Figure 3. A
third un¯anked copy occurs between two PPE genes
(RvD4) and the ®nal example, Rv3325-3326, corre-
sponds to the IS1547-associated copy described by
Fang et al. (1999) as characteristic of the variable
ipl locus (RvD5). A PCR assay (primers MolyF and
MolyR) designed to amplify this locus generated a
range of products from the different isolates
(Figure 4), demonstrating that this region is also
variable amongst the panel of isolates included in
the present study.
Discussion
Analysis of a 20 kb region of the M. tuberculosis
chromosome in a panel of 22 clinical isolates has
revealed surprisingly extensive genetic diversity.
Insertion and deletion events were identi®ed in
more than half of the isolates, with effects ranging
from disruption of individual open reading frames
to loss of as many as 13 genes. Variability within
this region is associated with a high frequency of
IS6110 insertions. We have identi®ed a total of 18
discrete insertion sites, clustered predominantly in
three subregions comprising plcD and the adjacent
Rv1754c, the cutinase gene, and an ISB9-like
element. A similar high frequency of IS6110 inser-
tion events within this region was observed in a
recent study of South African isolates (Sampson
et al., 1999). Where IS6110 is associated with loss of
Figure 4. Genetic diversity in the IS1547 region.PCR ampli®cation using primers spanning Rv3324c to Rv3328c revealed
extensive polymorphism amongst the panel of M. tuberculosis clinical isolates, with products ranging in size from 3 to 10 kb.
Lane 1, 1 kb ladder; 2, negative control; 3, H37Rv; 4, negative control; 5, TH19; 6, TH15; 7, TH12; 8, TH8; 9, TH4; 10, TH2;
11, TH1; 12, 1 kb ladder
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strongly suggests that homologous recombination
between adjacent copies of the insertion element has
been the cause of the deletion event. No clinical
isolate was found to have a double IS6110 insertion
in this region. The presence of two proximally
related IS elements may lead to an unstable
conformational structure of the genome, thus
precipitating homologous recombination. The pre-
sence of other IS6110-associated deletion regions in
M. tuberculosis H37Rv (RvD3±RvD5) (Brosch
et al., 2000) suggests that the 20 kb region is not
unique and probably represents an example of a
general phenomenon. These ®ndings identify gene
deletion as an important source of genetic diversity
amongst clinical isolates of M. tuberculosis.
Two important questions arise from this study.
Firstly, is the variable island unique, or is it
representative of a general mechanism of genetic
diversity in M. tuberculosis? Secondly, does the loss
of genes ± by insertion or by deletion ± have a
signi®cant effect on the biological properties of the
different isolates?
Diversity within the 20 kb region would appear
to be the result of its status as a `hot-spot' for
IS6110 insertion. Other IS6110 hot-spots have been
described (Fomukong et al., 1997; Fang et al., 1997;
Kurepina et al., 1998) and two mechanisms may
account for their occurrence. First, insertion at a
particular position may confer some selective
advantage which is then preserved during subse-
quent strain diversi®cation. Alternatively, local
structural features may make certain regions of the
genome particularly susceptible to insertion events.
The frequent ®nding of clustered insertions, as well
as insertions in similar locations but with different
orientation, is indicative of the existence of regions
prone to multiple insertion events as envisaged in
the second mechanism. Similarly, variation in
insertion patterns amongst contemporary H37Rv
isolates, as re¯ected in the present study and in the
comparison with H37Ra (Brosch et al., 1999), is
consistent with a high frequency of IS6110 activity
associated with the plcD gene, rather than immor-
talization of a single rare event. Interestingly, the
20 kb region overlaps with the RD14 BCG Pasteur
deletion described by Behr et al. (1999). The
absence of IS6110 in this case suggests that this
region may also be susceptible to alternative
mechanisms of deletion.
Turning to the biological consequences of geno-
typic variation in the plcD-cutinase region; recovery
of the deletion strains from patients with active
tuberculosis demonstrates that they retain the ability
to cause disease. An in¯uence of the deletion genes
on the course of infection is not excluded, however.
Phospholipase C has been identi®ed as a virulence
factor for several bacterial pathogens (Titball, 1993)
whilst cutinases, although principally associated
with the ability of fungi to penetrate the cutin layers
of plants (Schafer, 1993), may have been adapted for
hydrolysis of some related polymer during mamma-
lian infection. Both genes are found as part of
multicopy families. Interestingly, three of the phos-
pholipase C genes are deleted from M. bovis, leaving
plcD as the sole source of enzyme activity in the case
of bovine infection (Behr et al., 1999; Gordon et al.,
1999) and some clinical isolates of M. tuberculosis
demonstrate evidence of polymorphism in this
region (Vera-Cabrera et al., 1997). The different
homologues could provide some level of diversity in
terms of precise substrate speci®city, or may simply
contribute to an increase in the overall amount of
enzyme that can be produced. The loss of one or
more copies could therefore affect the balance of the
host±pathogen interaction. Other ORFs identi®ed in
the variable region encode protein products sharing
homology with glycosyl transferases (MT1800),
oxidoreductases (MT1801) and enzymes involved in
the synthesis of antibiotics (Rv1760).
The high prevalence of deletion events suggest
that they may be subject to positive selection, either
by some speci®c in¯uence on the process of
infection, as discussed above, or simply as a result
of removal of genes no longer required by the
bacteria. If this is the case, it would be anticipated
that the deletion strains represent a later stage of
M. tuberculosis evolution, as compared to those
having an intact complement of genes within the
variable region. Sreevatsan et al. (1997) have
proposed an evolutionary lineage for M. tubercu-
losis isolates based on speci®c nucleotide substitu-
tions in codons of the katG and gyrA genes.
Examination of these sequences within the present
panel failed to demonstrate any correlation. Dele-
tion and non-deletion isolates were distributed
amongst both early and late Sreevatsan groups
(Sales MPU, Ho TBL, Taylor GM, unpublished
observations). Thus, if deletion events do represent
an evolutionary progression, it is not one that is
coordinated with the sequence of katG/gyrA sub-
stitutions.
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study did not reveal any obvious association
between genotype and clinical presentation or
geographical origin. However, a more extensive
analysis ± such as that described recently by Rhee
et al. (1999) ± will be required in order to assess the
possible contribution of the deletion genes to the
overall process of human infection.
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